Security
PRCT · PROCEPT BioRobotics Corp
PRCTNASDAQCommon stockCurrentCIK 1588978Updated Sep 24, 2026
PRCT price & chart
Loading TradingView…
NASDAQ:PRCT on TradingView ↗In the news
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in PROCEPT BioRobotics Corporation of Class Action Lawsuit and Upcoming Deadlines – PRCT ↗
LAWSUIT NOTICE: NASDAQ: PRCT Investors who lost money with PROCEPT BioRobotics Corporation shares should contact the Shareholders Foundation ↗
INVESTOR DEADLINE: PROCEPT BioRobotics Corporation (PRCT) Investors with Substantial Losses Have Opportunity to Lead the PROCEPT Class Action Lawsuit Before September 22, 2026 Deadline ↗
Recent filings
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 508,081,000Source | 534,017,000Source | 404,717,000Source | 309,329,000Source |
| Property, Plant and Equipment, NetUSD | 30,399,000Source | 26,709,000Source | 28,748,000Source | 8,656,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 286,503,000Source | 333,725,000Source | 257,222,000Source | 221,859,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 83,533,000Source | 83,496,000Source | 48,376,000Source | 15,272,000Source |
| Inventory, NetUSD | 70,694,000Source | 56,168,000Source | 39,756,000Source | 28,543,000Source |
| Assets, CurrentUSD | 450,378,000Source | 481,842,000Source | 350,567,000Source | 272,626,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 9,648,000Source | 8,453,000Source | 5,213,000Source | 6,175,000Source |
| Operating Lease, Right-of-Use AssetUSD | 17,538,000Source | 18,941,000Source | 20,241,000Source | 23,481,000Source |
| Other Assets, NoncurrentUSD | 6,019,000Source | 2,555,000Source | 919,000Source | 51,000Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 142,211,000Source | 131,797,000Source | 123,965,000Source | 112,257,000Source |
| Stockholders’ equity: | ||||
| Preferred Stock, Value, IssuedUSD | 0Source | 0Source | 0Source | 0Source |
| Common Stock, Value, IssuedUSD | 0Source | 0Source | 0Source | 0Source |
| Additional Paid in CapitalUSD | 1,007,390,000Source | 948,091,000Source | 735,240,000Source | 545,753,000Source |
| Retained Earnings (Accumulated Deficit)USD | -641,557,000Source | -545,985,000Source | -454,572,000Source | -348,675,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | 37,000Source | 114,000Source | 84,000Source | -6,000Source |
| Stockholders' Equity Attributable to ParentUSD | 365,870,000Source | 402,220,000Source | 280,752,000Source | 197,072,000Source |
| Liabilities and EquityUSD | 508,081,000Source | 534,017,000Source | 404,717,000Source | 309,329,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 65,795,000Source | 53,133,000Source | 45,927,000Source | 35,290,000Source |
| Operating Lease, Liability, CurrentUSD | 2,214,000Source | 1,910,000Source | 1,683,000Source | 2,129,000Source |
| Accounts Payable, CurrentUSD | 17,285,000Source | 10,032,000Source | 13,499,000Source | 9,391,000Source |
| Operating Lease, Liability, NoncurrentUSD | 24,654,000Source | 26,868,000Source | 26,182,000Source | 23,975,000Source |
| Other Liabilities, NoncurrentUSD | 147,000Source | 324,000Source | 517,000Source | 0Source |
| Additional Financial Items | ||||
| Long-term Debt, Excluding Current MaturitiesUSD | 51,615,000Source | 51,472,000Source | 51,339,000Source | 51,213,000Source |
| Long-term Debt, Excluding Current MaturitiesUSD | 51,615,000Source | 51,472,000Source | 51,339,000Source | 51,213,000Source |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation, Depletion and AmortizationUSD | 6,390,000Source | 5,234,000Source | — | 2,841,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 47,603,000Source | 31,840,000Source | 19,134,000Source | 10,337,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | 898,000Source | 35,960,000Source | 33,103,000Source | 10,809,000Source |
| Increase (Decrease) in InventoriesUSD | 14,498,000Source | 17,235,000Source | 9,751,000Source | 15,251,000Source |
| Increase (Decrease) in Accounts PayableUSD | 6,648,000Source | -2,152,000Source | 5,789,000Source | 3,959,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -48,985,000Source | -99,213,000Source | -108,003,000Source | -80,382,000Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -9,356,000Source | -4,409,000Source | -25,206,000Source | -2,653,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 9,356,000Source | 4,409,000Source | 25,206,000Source | 2,653,000Source |
| Cash flows from financing activities: | ||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 11,193,000Source | 180,125,000Source | 167,795,000Source | 3,612,000Source |
| Repayments of Long-term DebtUSD | — | 0Source | 0Source | 50,000,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | -47,222,000Source | 76,503,000Source | 34,586,000Source | -79,423,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 289,541,000Source | 336,763,000Source | 260,260,000Source | 225,674,000Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 3,463,000Source | 3,970,000Source | 4,056,000Source | 4,291,000Source |
| Income Taxes Paid, NetUSD | 118,000Source | — | — | — |
| Additional Financial Items | ||||
| Share-based Payment Arrangement, ExpenseUSD | 47,603,000Source | 31,840,000Source | 19,134,000Source | 10,670,000Source |
| Amortization of Intangible AssetsUSD | 300,000Source | 300,000Source | 300,000Source | 300,000Source |
| Depreciation, Amortization and Accretion, NetUSD | — | — | 3,807,000Source | — |
| Gain (Loss) on Derivative Instruments, Net, PretaxUSD | 0Source | -114,000Source | -107,000Source | -283,000Source |
| Gain (Loss) on Extinguishment of DebtUSD | -157,000Source | 0Source | 0Source | -3,258,000Source |
| Income Tax Expense (Benefit)USD | 190,000Source | 0Source | 0Source | 0Source |
| InterestExpenseNonoperatingUSD | 3,586,000Source | 4,184,000Source | — | — |
| Inventory Write-downUSD | 565,000Source | 1,881,000Source | 995,000Source | 62,000Source |
| Investment Income, InterestUSD | 12,219,000Source | 10,895,000Source | 7,551,000Source | 2,497,000Source |
| Net Income (Loss) Attributable to ParentUSD | -95,572,000Source | -91,413,000Source | -105,897,000Source | -87,154,000Source |
| Operating ExpensesUSD | 300,085,000Source | 233,713,000Source | 180,219,000Source | 117,809,000Source |
| Operating Lease, ExpenseUSD | — | — | 8,400,000Source | 5,100,000Source |
| Other Nonoperating Income (Expense)USD | -156,000Source | -1,396,000Source | -176,000Source | -203,000Source |
| Proceeds from Issuance of Common StockUSD | 0Source | 164,523,000Source | 161,705,000Source | 2,409,000Source |
| Proceeds from Stock Options ExercisedUSD | 4,831,000Source | 11,075,000Source | 2,480,000Source | 4,008,000Source |
| Provision for Loan, Lease, and Other LossesUSD | — | 840,000Source | — | — |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Total RevenueUSD | 308,054,000Source | 224,498,000Source | 136,191,000Source | 75,014,000Source |
| Cost of Goods and Services Sold | — | — | — | — |
| Selling, General and Administrative ExpenseUSD | 228,808,000Source | 171,415,000Source | 131,773,000Source | 88,828,000Source |
| Operating Income (Loss)USD | -103,859,000Source | -96,614,000Source | -109,170,000Source | -80,724,000Source |
| Other Nonoperating Income (Expense)USD | -156,000Source | -1,396,000Source | -176,000Source | -203,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | -95,382,000Source | — | — | — |
| Income Tax Expense (Benefit)USD | 190,000Source | 0Source | 0Source | 0Source |
| Net Income (Loss) Attributable to ParentUSD | -95,572,000Source | -91,413,000Source | -105,897,000Source | -87,154,000Source |
| Earnings Per Share, BasicUSD per share | -1.72Source | -1.75Source | -2.24Source | -1.96Source |
| Earnings Per Share, DilutedUSD per share | -1.72Source | -1.75Source | -2.24Source | -1.96Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 55,544,000Source | 52,125,000Source | 47,255,000Source | 44,400,000Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 55,544,000Source | 52,125,000Source | 47,255,000Source | 44,400,000Source |
| Interest Expense (non-operating)USD | 3,586,000Source | 4,184,000Source | — | — |
| Additional Financial Items | ||||
| Amortization of Intangible AssetsUSD | 300,000Source | 300,000Source | 300,000Source | 300,000Source |
| Gain (Loss) on Derivative Instruments, Net, PretaxUSD | 0Source | -114,000Source | -107,000Source | -283,000Source |
| Gross ProfitUSD | 196,226,000Source | 137,099,000Source | 71,049,000Source | 37,085,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | -95,890,000Source | — | — | — |
| Interest ExpenseUSD | — | — | 3,995,000Source | 5,183,000Source |
| Investment Income, InterestUSD | 12,219,000Source | 10,895,000Source | 7,551,000Source | 2,497,000Source |
| Marketing and Advertising ExpenseUSD | 600,000Source | 500,000Source | 300,000Source | — |
| Operating ExpensesUSD | 300,085,000Source | 233,713,000Source | 180,219,000Source | 117,809,000Source |
| Operating Lease, ExpenseUSD | — | — | 8,400,000Source | 5,100,000Source |
| Research and Development ExpenseUSD | 71,277,000Source | 62,298,000Source | 48,446,000Source | 28,981,000Source |